Skip to main content

previous disabled Page of 15
and
  1. Article

    Open Access

    Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy

    The Naples Prognostic Score (NPS), integrating inflammatory and nutritional biomarkers, has been reported to be associated with the prognosis of various malignancies, but there is no report on intrahepatic cho...

    Cheng-Fei Du, Zhen-Yu Gao, Zhu-Ding Xu, Zheng-Kang Fang, Zi-Chen Yu in BMC Cancer (2024)

  2. Article

    Open Access

    UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer

    Understanding the metabolic changes in colorectal cancer (CRC) and exploring potential diagnostic biomarkers is crucial for elucidating its pathogenesis and reducing mortality. Cancer cells are typically deriv...

    Xuancheng Wang, Xuan Guan, Ying Tong, Yunxiao Liang, Zongsheng Huang in BMC Cancer (2024)

  3. Article

    Open Access

    Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan

    International guidelines recommend ivosidenib followed by modified FOLFOX (mFOLFOX) for advanced intrahepatic cholangiocarcinoma (ICC) with isocitrate dehydrogenase 1 (IDH1) mutations. Taiwan National Health Insu...

    Kuei-An Chen, Wei-Ming Huang, Eric Yi-Ting Chen, Pei-Kuan Ho, Chen-Han Chueh in BMC Cancer (2024)

  4. Article

    Open Access

    Associations between chronic obstructive pulmonary disease and ten common cancers: novel insights from Mendelian randomization analyses

    Chronic obstructive pulmonary disease (COPD) is a significant global health issue, suspected to elevate the risk for various cancers. This study sought to discern whether COPD serves as a risk marker or a caus...

    Shixia Liao, Yanwen Wang, Jian Zhou, Yuting Liu, Shuangfei He, Lanying Zhang in BMC Cancer (2024)

  5. Article

    Open Access

    Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

    Combination therapy is the primary treatment for unresectable hepatocellular carcinoma (u-HCC). The hepatic functional reserve is also critical in the treatment of HCC. In this study, u-HCC was treated with co...

    Yongqiang **ao, Wei Deng, Laihui Luo, Guoqing Zhu, ** **e, Yu Liu in BMC Cancer (2024)

  6. Article

    Open Access

    Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience

    Nasopharyngeal adenoid cystic carcinoma (NACC) is a rare malignancy with special biological features. Controversies exist regarding the treatment approach and prognostic factors in the IMRT era. This study aim...

    Wen-Bin Wu, Wu-Lin Cai, Ye-Hao Zou, Rui You, You-** Liu, Zhao-Di Yuan in BMC Cancer (2024)

  7. Article

    Open Access

    Retraction Note: Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer

    **-Yun Li, Wen-**ao Huang, **ao Zhou, Jie Chen, Zan Li in BMC Cancer (2024)

  8. Article

    Open Access

    Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis

    Colorectal cancer (CRC) is the 3rd most common malignancy with the liver being the most common site of metastases. The recurrence rate of colorectal liver metastases (CRLM) after liver resection (LR) is notabl...

    Yuan Tian, Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Bei Li, Geng Liu in BMC Cancer (2024)

  9. Article

    Open Access

    Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection

    The objective of this study was to investigate the correlation between spleen density and the prognostic outcomes of patients who underwent curative resection for colorectal cancer (CRC).

    Yunzhou **ao, **aoting Wen, Yingying Ying, **aoyan Zhang, Luyao Li in BMC Cancer (2024)

  10. Article

    Open Access

    Investigation of correlation between shear wave elastography and lymphangiogenesis in invasive breast cancer and diagnosis of axillary lymph node metastasis

    Accurate evaluation of axillary lymph node metastasis (LNM) in breast cancer is very important. A large number of hyperplastic and dilated lymphangiogenesis cases can usually be found in the pericancerous tiss...

    Bo Li, Shaochun Dai, Qiucheng Wang, Hui **g, Hua Shao, Lei Zhang, Ling Qin in BMC Cancer (2024)

  11. Article

    Open Access

    Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes

    Although immune cell therapy has long been used for treating solid cancer, its efficacy remains limited. Interferon (IFN)-producing killer dendritic cells (IKDCs) exhibit cytotoxicity and present antigens to r...

    Chih-Hao Fang, Wen-Fang Cheng, Ya-Fang Cheng, Keng-Li Lan, Jan-Mou Lee in BMC Cancer (2024)

  12. Article

    Open Access

    Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling

    Meningioma, the most prevalent intracranial tumor, possesses a significant propensity for malignant transformation. Circular RNAs (circ-RNAs), a class of non-coding RNAs, have emerged as crucial players in tum...

    Yongkai Huang, Zhihui Wu, Zewei Peng, Anmin Liu, Wen Yuan, Deqing Han in BMC Cancer (2024)

  13. Article

    Open Access

    Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial

    Definitive concurrent chemoradiotherapy (dCCRT) is the gold standard for the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). However, the potential benefits of consolidation chemothera...

    Chengcheng Fan, Xu Wang, **aoli Zheng, Yanan Sun, Ke Ye, Yue Jiang, **ao Liu in BMC Cancer (2024)

  14. Article

    Open Access

    The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

    The irreversible epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) afatinib and dacomitinib are approved for first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC)...

    Wen-Chien Cheng, Chi-Chien Lin, Wei-Chih Liao, Yu-Chao Lin, Chia-Hung Chen in BMC Cancer (2024)

  15. Article

    Open Access

    The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma

    Identifying lymph node metastasis areas during surgery for early invasive lung adenocarcinoma remains challenging. The aim of this study was to develop a nomogram mathematical model before the end of surgery f...

    Mengchao Xue, Junjie Liu, Zhenyi Li, Ming Lu, Huiying Zhang, Wen Liu in BMC Cancer (2024)

  16. Article

    Open Access

    A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens

    Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are the two most common immune checkpoints targeted in triple-negative breast cancer (BC). Refining patient selection for immunotherapy is non-tr...

    Yi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, Chia-Hung Yang, Yu-Ling Hung in BMC Cancer (2024)

  17. Article

    Open Access

    Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: a study of 1247 patients

    Since the Z0011 trial, the assessment of axillary lymph node status has been redirected from the previous assessment of the occurrence of lymph node metastasis alone to the assessment of the degree of lymph no...

    Hua Shao, Yixin Sun, Ziyue Na, Hui **g, Bo Li, Qiucheng Wang, Cui Zhang in BMC Cancer (2024)

  18. Article

    Open Access

    Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study

    Recently, with the advancement of medical technology, the postoperative morbidity of pelvic exenteration (PE) has gradually decreased, and it has become a curative treatment option for some patients with recur...

    Jie-Hai Yu, Chong-Jie Tong, Qi-Dan Huang, Yun-Lin Ye, Gong Chen, Hao Li in BMC Cancer (2024)

  19. Article

    Open Access

    RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP

    Ras gene mutation and/or overexpression are drivers in the progression of cancers, including colorectal cancer. Blocking the Ras signaling has become a significant strategy for cancer therapy. Previously, we c...

    Peng Lin, **g Qian, Cheng-Cheng Huang, Wen-Mang Xu, Yuan-Yuan Wang in BMC Cancer (2024)

  20. Article

    Open Access

    Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2

    The aim of this study is to evaluate an AAV vector that can selectively target breast cancer cells and to investigate its specificity and anti-tumor effects on breast cancer cells both in vitro and in vivo, of...

    Ya-feng Lv, Hao Zhang, Zhi Cui, Cui-jiao Ma, Yu-ling Li, Hua Lu, Hong-yan Wu in BMC Cancer (2023)

previous disabled Page of 15